top of page

enter here
A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants
About the study
NCT Trial Number
NCT04300621
The drug being studied
Ketamine


Sponsored by
Janssen Research & Development, LLC

Trial Start Date
Jun-20

About the participants
Age seeking
18 Years to 50 Years
gender
All

Primary condition of volunteers accepted
Healthy

Accepts healthy volunteers?
Yes
The purpose of the study in healthy participants is explore the safety, tolerability and the drug metabolism of different forms of sublingual S-Ketamine.

Locations
Belgium
SGS Life Science Services
Antwerpen, Belgium, 2060
Study Contact
844-434-4210
JNJ.CT@sylogent.com
bottom of page